New Zealand markets open in 7 hours

10x Genomics, Inc. (TXG)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
19.56-0.46 (-2.30%)
As of 10:00AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
631,733
618,727
516,409
490,490
298,845
Cost of revenue
223,288
209,414
120,386
74,091
58,468
Gross profit
408,445
409,313
396,023
416,399
240,377
Operating expenses
Research development
324,310
331,312
265,667
211,752
570,923
Selling general and administrative
337,353
343,330
298,300
257,560
202,326
Total operating expenses
661,663
674,642
563,967
469,312
773,249
Operating income or loss
-253,218
-265,329
-167,944
-52,913
-532,872
Interest expense
11
33
476
866
1,682
Total other income/expenses net
1,617
-307
-198
-142
-1,454
Income before tax
-233,224
-248,763
-161,971
-53,715
-534,476
Income tax expense
6,560
6,336
4,029
4,508
8,255
Income from continuing operations
-239,784
-255,099
-166,000
-58,223
-542,731
Net income
-239,784
-255,099
-166,000
-58,223
-542,731
Net income available to common shareholders
-239,784
-255,099
-166,000
-58,223
-542,731
Basic EPS
-1.46
-2.18
-1.46
-0.53
-5.37
Diluted EPS
-1.46
-2.18
-1.46
-0.53
-5.37
Basic average shares
113,859
117,165
113,859
110,348
101,152
Diluted average shares
113,859
117,165
113,859
110,348
101,152